The ketogenic diet is not for everyone: contraindications, side effects, and drug interactions.
Level 5 - mechanism / opinion, no new human data
Narrative clinical review synthesizing expert knowledge and literature without systematic review methodology.
PubMed 41486865 · doi:10.1080/07853890.2025.2603016
What was done
This narrative review synthesized clinical safety considerations for the ketogenic diet, focusing on absolute and relative contraindications, medical conditions requiring heightened caution, drug-diet interactions, and commonly reported adverse effects across clinical and research settings.
What was found
The abstract reports clinical safety categories without quantitative metrics: - Absolute contraindications identified include rare inborn errors of metabolism (pyruvate carboxylase deficiency, carnitine transport or utilization defects, fatty acid oxidation pathway disorders) and porphyria. - Relative contraindications include acute pancreatitis, advanced liver or kidney disease, familial hypercholesterolemia, and concurrent propofol administration. - High-caution clinical contexts include type 1 or 2 diabetes on glucose-lowering medications, medically treated hypertension, gallbladder disease or post-cholecystectomy status, electrolyte disturbances, cardiac arrhythmias, pregnancy, lactation, underweight status, intense exercise, psychosocial stress, and postoperative recovery. - Key drug interactions involve SGLT2 inhibitors, metformin, GLP-1 receptor agonists, insulin, sulfonylureas, antiepileptic agents, diuretics, lipophilic drugs, and corticosteroids. - Frequently reported side effects include transient "keto flu" (fatigue, headache, nausea), gastrointestinal complaints, polyuria, and hypoglycemia.
Why it matters
As the ketogenic diet expands into broader clinical use for metabolic and neurological conditions, this synthesis provides clinicians with a practical checklist of metabolic risks and pharmacotherapy interactions to guide safe patient selection.
Limits
The paper is a non-systematic narrative review and does not report quantitative effect sizes, incidence rates of adverse events, or a formal methodology for study inclusion and risk-of-bias assessment.
Cited by
- supports Carnitine deficiency is an inborn error of metabolism that can prevent individuals from achieving a low Glucose Ketone Index without carnitine supplementation.